Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
98 EUR | -1.01% | -.--% | +2.08% |
Sales 2024 * | 42.98B 40.13B 3,397B | Sales 2025 * | 52.62B 49.13B 4,159B | Capitalization | 811B 758B 64,133B |
---|---|---|---|---|---|
Net income 2024 * | 11.93B 11.14B 943B | Net income 2025 * | 16.55B 15.45B 1,308B | EV / Sales 2024 * | 19.3 x |
Net Debt 2024 * | 18.06B 16.86B 1,427B | Net Debt 2025 * | 15B 14B 1,185B | EV / Sales 2025 * | 15.7 x |
P/E ratio 2024 * |
67.4
x | P/E ratio 2025 * |
48.5
x | Employees | - |
Yield 2024 * |
0.58% | Yield 2025 * |
0.66% | Free-Float | 99.8% |
Latest transcript on Eli Lilly and Company
1 day | -1.01% |
Managers | Title | Age | Since |
---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 56 | 31/12/95 |
Ruth Gimeno
PSD | President | - | - |
David Hyman
CTO | Chief Tech/Sci/R&D Officer | - | 15/10/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 24/01/21 | |
Ralph Alvarez
BRD | Director/Board Member | 68 | 31/03/09 |
Jon Fyrwald
BRD | Director/Board Member | 63 | 31/12/04 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.68% | 640B | |
-6.30% | 353B | |
+19.33% | 333B | |
+9.58% | 302B | |
+17.02% | 246B | |
+2.66% | 225B | |
+12.84% | 218B | |
+9.25% | 168B | |
-5.26% | 155B |
- Stock Market
- Equities
- LLY Stock
- LLY Stock